Non-integrating Vector iPSC Induction from Neural Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating induced pluripotent stem cells (iPSCs) from domestic and farm animals, such as horses, dogs, cats, pigs, and cattle, face issues with integrating retroviral vectors causing mutations and immunogenicity, while non-integrating vectors are less effective and produce rare, difficult-to-maintain clones with undesirable phenotypes.
Innovation Solution
Culturing neural stem cells from these animals in the presence of non-integrating vectors expressing reprogramming factors like Oct4, Sox2, and Klf4, which significantly increases reprogramming efficiency and maintains pluripotency, with the use of a Sendai virus and specific growth medium components like knockout serum replacement and gp130 agonists, resulting in iPSCs that can differentiate into all three germ layers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If integrating retroviral or lentiviral vectors are used to generate iPSCs from domestic animals, then reprogramming efficiency is improved, but mutation risk and immunogenicity increase
Solution Approach 1:
The patent extracts the harmful integrating capability from the viral vector system by using non-integrating viral vectors (adenoviral, adeno-associated viral, respiroviral, poxviral, episomal, plasmid, or artificial chromosome vectors) that deliver reprogramming factors without integrating into the host genome, thereby eliminating mutation risks while maintaining reprogramming efficiency
Solution Approach 2:
The patent uses viral vectors as intermediary carriers to deliver reprogramming factors (Oct4, Sox2, Klf4, and/or c-Myc) into somatic cells. These vectors act as temporary mediators that facilitate gene expression without permanent genomic integration, allowing efficient reprogramming while avoiding the harmful effects of integration
2Object-affected harmful factors
If non-integrating vectors are used to avoid mutations, then safety is improved, but reprogramming efficiency decreases and clone maintenance becomes difficult
Solution Approach 1:
The patent changes the parameters of the viral vector system by selecting specific non-integrating vector types (adenoviral, adeno-associated viral, respiroviral, poxviral, episomal, plasmid, or artificial chromosome vectors) with optimized properties for delivering reprogramming factors, achieving both safety and efficiency
Solution Approach 2:
The patent employs a composite approach combining non-integrating viral vectors with specific reprogramming factor combinations (Oct4, Sox2, Klf4, and/or c-Myc) and optimized culture conditions (including feeder layers and specific media components) to achieve high reprogramming efficiency without integration risks
3Ease of manufacture
If fibroblasts are used as starting material, then ease of derivation is improved, but reprogramming efficiency remains limited
Solution Approach 1:
The patent changes the starting cell type parameter from fibroblasts to neural stem cells (NSCs), which possess inherent properties that make them more responsive to reprogramming factors, thereby significantly improving reprogramming efficiency while maintaining ease of derivation through minimally invasive procedures
Data Source
AI summary
A method of inducing pluripotency in somatic cells derived from a non-human domestic animal or farm animal comprises culturing neural stem cells (NSCs) in the presence of vectors that express one or more reprogramming factors. Canine, porcine and bovine iPSCs are obtained with distinct genetic marker profiles.